Translator Disclaimer
8 February 2011 The potential role of functional inhibition of T regulatory cells by anti-TGFβ antibody in photodynamic therapy of renal cancer
Author Affiliations +
Proceedings Volume 7900, Biophotonics and Immune Responses VI; 790003 (2011) https://doi.org/10.1117/12.876523
Event: SPIE BiOS, 2011, San Francisco, California, United States
Abstract
Photodynamic therapy (PDT) has been shown to be an effective locally ablative anti-cancer treatment that has the additional advantage of inducing tumor-directed immune response. We hypothesized that PDT could be combined with anti-transforming growth factor (TGF) beta antibody that does not significantly affect the population of cytotoxic T lymphocytes (CTL) but at the same time, has the potential to decrease the immunosuppressive effects of regulatory T-cells (Treg) mediated by TGF beta. This hypothesis was tested with aTGF-beta antibody combined with BPD-mediated PDT in a BALB/c renal cell carcinoma model. Evidence of positive benefits of the combination therapy over individual treatments alone was obtained.
© (2011) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Pawel Mroz and Michael R. Hamblin "The potential role of functional inhibition of T regulatory cells by anti-TGFβ antibody in photodynamic therapy of renal cancer", Proc. SPIE 7900, Biophotonics and Immune Responses VI, 790003 (8 February 2011); https://doi.org/10.1117/12.876523
PROCEEDINGS
10 PAGES


SHARE
Advertisement
Advertisement
Back to Top